We are pleased to announce that last week Yas Holding LLC completed the acquisition of a significant majority shareholding in Geltec Healthcare FZE. Located in Dubai’s Jebel Ali area, Geltec Healthcare FZE is part of a renowned pharma and nutraceutical group with a global presence. The acquisition was completed through our dedicated healthcare investment group, Global One Healthcare Holding LLC.

The facility is geared to produce dietary supplements and pharmaceutical products in soft gelatine capsules and gelatine enrobed tablets, with a rated manufacturing capacity of 1.5 billion units per annum.

The company has a state-of-the-art manufacturing facility, which is the largest soft gelatine capsule manufacturing and packaging facility in the region, with the scope to expand into various other dosage forms.

Yas Holding plans to invest in further plant expansion to include oral solid tablets, and potentially inhalers and/or injectable lines. The facility is approved by the UAE Ministry of Health and has also received GCC and EU GMP certifications, amongst other approvals.

Commenting on the latest acquisition, Mr. Murshed Al Redaini, our Group Chief Executive Officer of Yas Holding said “Yas Holding is pleased to announce our acquisition of Geltec Healthcare FZE. The addition of their production facilities in the UAE will bring further strength to our pharmaceutical manufacturing and distribution value chain, whilst also complementing our existing healthcare portfolio.”

He further added “Our Healthcare Division continues to expand as we aim to realise our strategy of becoming a significant player in the region’s healthcare industry. With recent investments in leading bio-pharmaceuticals and innovative manufacturing solutions, Yas Holding is delivering on its commitment to healthcare outcomes and patient quality of life. Our healthcare portfolio includes biopharma, medical supply chain provision, hospital and clinic management, manufacturing, healthcare technology, and occupational health and wellness.”